Discover and read the best of Twitter Threads about #CABG
Most recents (7)
📌#Revisión & #Metaanálisis. Revascularización en Cardiopatía Isquémica c/FEY <35%: para quienes y como.
4⃣ECR & 2.4K👥
🔹HEART (#HF #Revascularisation Trial)
🔸STICH (Surgical Treatment for #Ischemic HF)
🔹PARR-2 (PET and Recovery Following Revascularization)
🔸REVIVED-BCIS2
4⃣ECR & 2.4K👥
🔹HEART (#HF #Revascularisation Trial)
🔸STICH (Surgical Treatment for #Ischemic HF)
🔹PARR-2 (PET and Recovery Following Revascularization)
🔸REVIVED-BCIS2
🔹HEART (6%👥) FEY 24%. CABG vs OMT. Viabilidad todos.
🔸STICH/STICHES (49%👥) FEY 28%. CABG vs OMT. Viabilidad discrecional🩺.
🔹PARR-2 (17%👥) FEY 27%. tto guiado x imágenes
🔸REVIVED (28%👥) FEY 27%. PCI vs OMT. 14% TCI y 58% DA prox. Viabilidad todos.
👇Para guardar
🔸STICH/STICHES (49%👥) FEY 28%. CABG vs OMT. Viabilidad discrecional🩺.
🔹PARR-2 (17%👥) FEY 27%. tto guiado x imágenes
🔸REVIVED (28%👥) FEY 27%. PCI vs OMT. 14% TCI y 58% DA prox. Viabilidad todos.
👇Para guardar
📌Rol de la isquemia:
🔸Basado en estudios históricos: MASS II.
🔹STICH (nuclear) no mostró beneficio y sí un pequeño subanálisis del ISCHEMIA (gráfico)
🔸Aún👉recomendación clase I p/👥c/ enf. multivaso + isquemia inducible y FEY severa, aunque la evidencia actual no lo avala⛔️
🔸Basado en estudios históricos: MASS II.
🔹STICH (nuclear) no mostró beneficio y sí un pequeño subanálisis del ISCHEMIA (gráfico)
🔸Aún👉recomendación clase I p/👥c/ enf. multivaso + isquemia inducible y FEY severa, aunque la evidencia actual no lo avala⛔️
1) Welcome to an #accredited #tweetorial on a unique emerging (in Ph3 now) option for specifically reversing the #antiplatelet effects of #ticagrelor: it's #bentracimab. Expert faculty is antithrombotic agent reversal guru @md_pollack of @UMMCnews, working to create #AHealthierMS
2) This program is intended for #healthcare professionals and is supported by an educational grant from PhaseBio Pharmaceuticals. Faculty disclosures are listed at cardiometabolic-ce.com/disclosures/, and prior programs are available for 🆓CE/#CME credit at cardiometabolic-ce.com.
3) It is an unfortunate fact of life that one cannot prescribe #anticoagulant or #antiplatelet (together, #antithrombotic) therapy without increasing a patient's #bleedingrisk. That is why it should be an individualized risk:benefit decision, ideally . . .
@ACCinTouch @AHAScience @JACCJournals @CircAHA 2020 VHD guidelines. Here's a series of tweet-synopsis. First: #TAVR and AS. Key wasn't just Figure 3 but Table 14 where it highlights specifics favoring SAVR vs TAVR. To me it's informative. @AATSHQ @STS_CTsurgery @EACTS @escardio
#2: Bicuspid AV: recommendations on management of ascending aorta and root @NimeshDesaiMD @OPreventzaMD @OuzounianMD @EricRoselliMD @AortaSurg @DrZeigler1 @AATSHQ @STS_CTsurgery @ACCinTouch @AHAScience @JACCJournals @CircAHA
#3: Primary MR: TEER (E2E repair) #MitraClip is now Class 2A in high or prohibitive pts with "favorable" anatomy. Asymptomatic but LV dysfn DMR is Class 1 for surgery if repair possible @GAilawadiMD @DrMoritzWvB @TsuyoshiKaneko1 @AATSHQ @STS_CTsurgery @ACCinTouch @AHAScience
Readdressing the validity of repeat revascularization as an outcome measure in #PCI Vs #CABG. For readers in a hurry:
1) visit @cardiomicsclub cardiomics.club/2019/12/20/rea…
2) go to @JACCJournals and listen podcast onlinejacc.org/content/74/25/…
3) read this thread! (Laziest!)
1) visit @cardiomicsclub cardiomics.club/2019/12/20/rea…
2) go to @JACCJournals and listen podcast onlinejacc.org/content/74/25/…
3) read this thread! (Laziest!)
Repeat revasc has been used in multiple #PCI Vs #CABG RCTs, consistently favoring CABG, making composite outcomes mostly influenced by repeat revasc in many scenarios. Also, repeat revasc has been cited as (at least part of) the justification for recommending CABG over PCI
However, repeat revasc (alone, no associated MI) has many clinical and methdological limitations warranting deep understanding for an appropriate appraisal, summarized in this slide. First one is confounding by indication: repeat revasc is indicated, does not happen spontaneously
#WeeklyCardioReview Left main: #PCI or #CABG? A methodological review of #EXCELtrial and #NOBLEtrial, research in context and final answer to what should I do with my patient with #LMdisease. Stay tuned, enjoy and comment
#EXCELtrial Intended population: 2010-2014
1. LM >70% visually, or >50% hemodynamically significant
2. Heart team suitable for both Tx
3. SYNTAX score <32
1. LM >70% visually, or >50% hemodynamically significant
2. Heart team suitable for both Tx
3. SYNTAX score <32
Actual population:
Core lab detected high SYNTAX score (≥33) in 24.2%
Distal LM 80.5%
2 or 3 VD 51.3%
Most common exclusion criteria: Disease too complex for PCI (31.9%)
1905 pts randomized, small cross overs, balanced LTFU
Core lab detected high SYNTAX score (≥33) in 24.2%
Distal LM 80.5%
2 or 3 VD 51.3%
Most common exclusion criteria: Disease too complex for PCI (31.9%)
1905 pts randomized, small cross overs, balanced LTFU
(1/18) A Brief History of Coronary Angioplasty and the Roots of the Interventional Cardiology Field -- a #Tweetorial
#Cardiotwitter #FOAMed #ACCFIT #histmed @ACCCardioEd
Courtesy of @PopmaJeffrey & @ACCinTouch
#Cardiotwitter #FOAMed #ACCFIT #histmed @ACCCardioEd
Courtesy of @PopmaJeffrey & @ACCinTouch
(2/18) Dr. Werner Forssman (🇩🇪) performs 1st human #RHC (1929) by inserting a 65cm urologic catheter into his own antecubital vein and walking up to the X-ray department for imaging. Reportedly, he did this repeatedly! He left urology for primary care & shared @NobelPrize (1956).
(3/18) Dr. Fariñas (🇨🇺) performs aortography via femoral🔪 cut down (1941). Dr. Euler (🇩🇪) performs thoracic angiography by direct aorta puncture via esophagus (1949). Drs. Cournand & Dickinson (🇺🇸) open 1st US #cath lab (1945), publish extensively, and shared @NobelPrize (1956).
#12leadthursday: 80M with hx #CABG with progressive decreased ET
Quiz urself before scrolling down! ✔️
What’s the rhythm? 🤔
What would you do next? 🤔
#FOAMed #cardiotwitter #MedEd
Quiz urself before scrolling down! ✔️
What’s the rhythm? 🤔
What would you do next? 🤔
#FOAMed #cardiotwitter #MedEd
